Inactive Instrument

Rennova Health, Inc.

RNVA

US7597578837

Healthcare Facilities & Services

Rennova Health, Inc. Appoints Seamus Lagan as Interim Chief Financial Officer

October 29, 2017

The Board of Directors of Rennova Health, Inc. has appointed Seamus Lagan, the Company's Chief Executive Officer, as the Company's Interim Chief Financial Officer.

Latest news about Rennova Health, Inc.

Rennova Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Rennova Health, Inc. Announces the Opening of its First Alcohol and Drug Treatment Facility	23-08-14	CI
Rennova Health, Inc. Auditor Raises 'Going Concern' Doubt	23-04-16	CI
Rennova Health Seeks Acquisitions	22-09-14	CI
Rennova Health, Inc. Auditor Raises 'Going Concern' Doubt	22-04-14	CI
Rennova Health, Inc. announced that it has received $1.5 million in funding	22-03-31	CI
Rennova Health, Inc. announced that it expects to receive $1.5 million in funding	22-01-30	CI
Rennova Health, Inc. announced that it has received $4 million in funding	21-12-09	CI
Rennova Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
Rennova Health, Inc. announced that it expects to receive $4 million in funding	21-10-27	CI
Rennova Health, Inc. announced that it has received $1 million in funding	21-09-29	CI
Rennova Health, Inc. announced that it expects to receive $1 million in funding	21-09-06	CI
Rennova Health, Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2021	21-08-16	CI
Rennova Health, Inc. announced that it has received $4 million in funding from Sabby Management, LLC	21-08-12	CI
VisualMED Clinical Solutions Corp. completed the acquisition of Health Technology Solutions, Inc. and Advanced Molecular Services Group, Inc. from Rennova Health, Inc.	21-06-24	CI
Rennova Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-06-14	CI
Rennova Health Seeks Acquisitions	21-06-14	CI
VisualMED Clinical Solutions Corp. entered into an agreement to acquire Health Technology Solutions, Inc. and Advanced Molecular Services Group, Inc. from Rennova Health, Inc.	21-05-16	CI
Rennova Health, Inc. announced that it expects to receive $4 million in funding from Sabby Management, LLC	21-05-09	CI
Rennova Health, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-15	CI
Rennova Health, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-16	CI
Rennova Health, Inc. to Deploy Rapid Covid-19 Test At Two Hospitals in Tennessee and Rural Clinic in Kentucky	20-09-14	CI
Rennova Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-07-17	CI
Rennova Health, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-06-29	CI
Rennova Health, Inc. Announces SEC Order on Delay of Filling of Annual Report	20-03-30	CI

Rennova Health, Inc. (Rennova), formerly CollabRx, Inc., is a provider of health care services to healthcare providers, patients and individuals. The Company operates in two segments: Clinical Laboratory operations, and Hospital operations. The Company is a healthcare enterprise that delivers products and services, including laboratory diagnostics, healthcare technology solutions, and revenue cycle management and intends to provide financial services, to medical providers. Rennova's principal line of business is clinical laboratory blood and urine testing services. It is also engaged in the provision of urine drug toxicology testing to physicians, clinics and rehabilitation facilities in the United States. Its clinical laboratories include Biohealth Medical Laboratory, Inc.; Alethea Laboratories, Inc.; International Technologies, LLC; EPIC Reference Labs, Inc., and Epinex Diagnostics Laboratories, Inc.

Sector

Healthcare Facilities & Services

More about the company

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
SONIC HEALTHCARE LIMITED	-24.16%	7.76B
RADNET, INC.	+68.65%	4.33B
SYNLAB AG	-2.98%	2.64B
DR. LAL PATHLABS LIMITED	+2.72%	2.63B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-46.17%	2.16B
NEOGENOMICS, INC.	-15.27%	1.75B
FLEURY S.A.	-22.12%	1.46B
METROPOLIS HEALTHCARE LIMITED	+13.62%	1.17B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-43.81%	1.14B

Medical & Diagnostic Laboratories